# Doccla

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/doccla

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.doccla.com
- Total disclosed funding: $66M
- Latest round: Series B (Jul 17, 2024)
- Investors on record: 7

## About

Based in the UK, Doccla LTD is a healthcare technology company specializing in virtual care solutions for monitoring and managing patient health, enhancing continuity of care across various healthcare settings.Doccla LTD is a healthcare technology firm focused on providing innovative virtual care solutions. Founded in 2019 in London, UK, the company has successfully raised GBP 35.30 mn in Series B funding as of July 2024, led by Lakestar with participation from Elaia Partners and other returning investors. The company has completed a total of 4 deals to date, and has shown a commitment to expanding its operations within the healthcare sector.Doccla provides a comprehensive suite of virtual care solutions aimed at enhancing patient monitoring and management across the healthcare continuum. Their core product offerings include a remote patient monitoring (RPM) platform that utilizes ergonomic, non-invasive medical devices to gather vital signs, enabling healthcare professionals to monitor patients in real-time. This service is particularly beneficial for individuals with chronic conditions requiring continuous or high-frequency monitoring, such as heart failure or non-alcoholic fatty liver disease. Doccla's solutions are operational in 11 European countries, effectively partnering with various healthcare providers, including NHS Trusts and community health services, to implement proactive care programs designed to reduce emergency admissions and optimize clinical capacity. The target customer base encompasses both healthcare institutions and patients, with more than 10,000 patients currently benefiting from their end-to-end virtual care services.Doccla's revenue model is structured around partnerships with healthcare providers, leveraging a business-to-business (B2B) framework. The company engages in contractual agreements with NHS Trusts and integrated care boards, providing access to its virtual care solutions in exchange for a fee that reflects the value delivered in terms of cost savings and improved patient outcomes. Transactions typically involve a subscription-based service model, where healthcare institutions pay for the ongoing use of Doccla's RPM platform and associated services, which also includes costs related to the logistical management of medical devices and continuous support from clinical teams.In July 2024, Doccla LTD raised GBP 35.30 mn in Series B funding, which will be utilized for geographical expansion. The company plans to enter new markets to enhance its reach and impact in virtual healthcare solutions. Specific details about new product launches have not been disclosed, but the funding will support the company's strategy to broaden its operational footprint and serve a wider patient population across Europe.

## Funding rounds

- Series B, Jul 17, 2024, $46M — General Catalyst Partners, Elaia Partners, Speedinvest, Lakestar, Bertelsmann Investments
- Series A, Aug 23, 2022, $17M — General Catalyst Partners, Speedinvest, Giant Ventures, Meridian Health Ventures
- Seed, Aug 17, 2021, $3.3M — Speedinvest, Giant Ventures

## Investors

- Speedinvest (https://capitalatlas.ai/funds/speedinvest) — Seed, Series A, Series B
- Giant Ventures (https://capitalatlas.ai/funds/giant-ventures) — Seed, Series A
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series A, Series B
- Meridian Health Ventures (https://capitalatlas.ai/funds/meridian-health-ventures) — Series A
- Elaia Partners (https://capitalatlas.ai/funds/elaia-partners) — Series B
- Lakestar (https://capitalatlas.ai/funds/lakestar) — Series B
- Bertelsmann Investments (https://capitalatlas.ai/funds/bertelsmann-investments) — Series B